About Contact Us Careers
Sign In

Pulmonary Fibrosis Treatment Market - Top Companies and Manufacturers

  • Report ID: 2396
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Pulmonary Fibrosis Treatment Landscape

    • Boehringer Ingelheim GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd.
    • FibroGen, Inc.
    • Merck & Co., Inc.
    • Bristol-Myers Squibb Company
    • MediciNova, Inc.
    • Genentech, Inc.
    • Cipla Inc.
    • Biogen
    • Galapagos NV
Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 2396
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The risk factors associated with pulmonary fibrosis such as geriatric population, smoking, exposure to toxins, cancer treatments along with some genetic factors are estimated to drive the growth of the market.

The market is anticipated to attain a significantly high CAGR over the forecast period, i.e. 2020-2028.

Growing presence of leading drug manufacturers in Asia Pacific is anticipated to provide more business opportunities in the region for the market growth.

The major players in the market are Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., FibroGen, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, MediciNova, Inc., Genentech, Inc., Cipla Inc., Biogen and Galapagos NV.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample